{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:29:20Z","timestamp":1787239760953,"version":"build-2736575974"},"reference-count":20,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2014]]},"DOI":"10.1248\/bpb.b13-00843","type":"journal-article","created":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T20:26:32Z","timestamp":1398889592000},"page":"858-864","source":"Crossref","is-referenced-by-count":41,"title":["Anti-allodynic and Neuroprotective Effects of Koumine, a Benth Alkaloid, in a Rat Model of Diabetic Neuropathy"],"prefix":"10.1248","volume":"37","author":[{"given":"Qian","family":"Ling","sequence":"first","affiliation":[{"name":"Department of Pharmacology, College of Pharmacy, Fujian Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Pharmacy, Fujian Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Xia","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Pharmacy, Fujian Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Pharmacy, Fujian Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Pharmacy, Fujian Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hui","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Pharmacy, Fujian Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Xi","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Pharmacy, Fujian Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. <i>Pharmacol. Ther.<\/i>, 120, 1\u201334 (2008)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Dworkin RH, O\u2019Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS. Pharmacologic management of neuropathic pain: evidence-based recommendations. <i>Pain<\/i>, 132, 237\u2013251 (2007).","DOI":"10.1016\/j.pain.2007.08.033"},{"key":"3","unstructured":"3) Tomlinson DR, Gardiner NJ. Glucose neurotoxicity. <i>Nat. Rev. Neurosci.<\/i>, 9, 36\u201345 (2008)."},{"key":"4","unstructured":"4) Xu Y, Qiu HQ, Liu H, Liu M, Huang ZY, Yang J, Su YP, Yu CX. Effects of koumine, an alkaloid of <i>Gelsemium elegans<\/i> BENTH., on inflammatory and neuropathic pain models and possible mechanism with allopregnanolone. <i>Pharmacol. Biochem. Behav.<\/i>, 101, 504\u2013514 (2012)."},{"key":"5","unstructured":"5) Su YP, Shen J, Xu Y, Zheng M, Yu CX. Preparative separation of alkaloids from <i>Gelsemium elegans<\/i> BENTH. using pH-zone-refining counter-current chromatography. <i>J. Chromatogr. A<\/i>, 1218, 3695\u20133698 (2011)."},{"key":"6","unstructured":"6) Talbot S, Chahmi E, Dias JP, Couture R. Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy. <i>J. Neuroinflammation<\/i>, 7, 36 (2010)."},{"key":"7","unstructured":"7) Takasaki I, Andoh T, Nojima H, Shiraki K, Kuraishi Y. Gabapentin antinociception in mice with acute herpetic pain induced by herpes simplex virus infection. <i>J. Pharmacol. Exp. Ther.<\/i>, 296, 270\u2013275 (2001)."},{"key":"8","unstructured":"8) Munro G, Storm A, Hansen MK, Dyhr H, Marcher L, Erichsen HK, Sheykhzade M. The combined predictive capacity of rat models of algogen-induced and neuropathic hypersensitivity to clinically used analgesics varies with nociceptive endpoint and consideration of locomotor function. <i>Pharmacol. Biochem. Behav.<\/i>, 101, 465\u2013478 (2012)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Mitrirattanakul S, Ramakul N, Guerrero AV, Matsuka Y, Ono T, Iwase H, Mackie K, Faull KF, Spigelman I. Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. <i>Pain<\/i>, 126, 102\u2013114 (2006).","DOI":"10.1016\/j.pain.2006.06.016"},{"key":"10","unstructured":"10) Wu YB, Shi LL, Wu YJ, Xu WH, Wang L, Ren MS. Protective effect of gliclazide on diabetic peripheral neuropathy through Drp-1 mediated-oxidative stress and apoptosis. <i>Neurosci. Lett.<\/i>, 523, 45\u201349 (2012)."},{"key":"11","unstructured":"11) Cheng JK, Chou RC, Hwang LL, Chiou LC. Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain. <i>J. Pharmacol. Exp. Ther.<\/i>, 307, 1065\u20131071 (2003)."},{"key":"12","unstructured":"12) Jagodic MM, Pathirathna S, Nelson MT, Mancuso S, Joksovic PM, Rosenberg ER, Bayliss DA, Jevtovic-Todorovic V, Todorovic SM. Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. <i>J. Neurosci.<\/i>, 27, 3305\u20133316 (2007)."},{"key":"13","unstructured":"13) Liu M, Huang HH, Yang J, Su YP, Lin HW, Lin LQ, Liao WJ, Yu CX. The active alkaloids of <i>Gelsemium elegans<\/i> BENTH. are potent anxiolytics. <i>Psychopharmacology <\/i>(Berl.), 225, 839\u2013851 (2013)."},{"key":"14","unstructured":"14) Bordet T, Buisson B, Michaud M, Abitbol JL, Marchand F, Grist J, Andriambeloson E, Malcangio M, Pruss RM. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy. <i>J. Pharmacol. Exp. Ther.<\/i>, 326, 623\u2013632 (2008)."},{"key":"15","unstructured":"15) Shi X, Chen Y, Nadeem L, Xu G. Beneficial effect of TNF-alpha inhibition on diabetic peripheral neuropathy. <i>J. Neuroinflammation<\/i>, 10, 69 (2013)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Giatti S, Pesaresi M, Cavaletti G, Bianchi R, Carozzi V, Lombardi R, Maschi O, Lauria G, Garcia-Segura LM, Caruso D, Melcangi RC. Neuroprotective effects of a ligand of translocator protein-18\u2009kDa (Ro5-4864) in experimental diabetic neuropathy. <i>Neuroscience<\/i>, 164, 520\u2013529 (2009).","DOI":"10.1016\/j.neuroscience.2009.08.005"},{"key":"17","unstructured":"17) Cermenati G, Giatti S, Cavaletti G, Bianchi R, Maschi O, Pesaresi M, Abbiati F, Volonterio A, Saez E, Caruso D, Melcangi RC, Mitro N. Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy. <i>J. Neurosci.<\/i>, 30, 11896\u201311901 (2010)."},{"key":"18","unstructured":"18) Melcangi RC, Giatti S, Pesaresi M, Calabrese D, Mitro N, Caruso D, Garcia-Segura LM. Role of neuroactive steroids in the peripheral nervous system. <i>Front Endocrinol <\/i>(Lausanne), 2, 104 (2011)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Leonelli E, Bianchi R, Cavaletti G, Caruso D, Crippa D, Garcia-Segura LM, Lauria G, Magnaghi V, Roglio I, Melcangi RC. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. <i>Neuroscience<\/i>, 144, 1293\u20131304 (2007).","DOI":"10.1016\/j.neuroscience.2006.11.014"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Xiao WH, Zheng FY, Bennett GJ, Bordet T, Pruss RM. Olesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel. <i>Pain<\/i>, 147, 202\u2013209 (2009).","DOI":"10.1016\/j.pain.2009.09.006"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/37\/5\/37_b13-00843\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T01:43:07Z","timestamp":1615858987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/37\/5\/37_b13-00843\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b13-00843","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}